115 related articles for article (PubMed ID: 74127)
1. [Possibilities for the clinical use of 5-azacytidine].
Veselý J; Cihák A
Vopr Onkol; 1977; 23(10):65-73. PubMed ID: 74127
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of cystostatic effect of 5-azacytidine and its usefulness in clinic].
Veselý J; Cihák A
Cas Lek Cesk; 1975 May; 114(20):607-11. PubMed ID: 48423
[No Abstract] [Full Text] [Related]
3. 5-azacytidine.
IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():37-46. PubMed ID: 6168559
[No Abstract] [Full Text] [Related]
4. 5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia.
Von Hoff DD; Slavik M; Muggia FM
Ann Intern Med; 1976 Aug; 85(2):237-45. PubMed ID: 60073
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute leukemia with 5-azacytidine (NSC-102816).
McCredie KB; Bodey GP; Burgess MA; Gutterman JU; Rodriguez V; Sullivan MP; Freireich EJ
Cancer Chemother Rep; 1973; 57(3):319-23. PubMed ID: 4127393
[No Abstract] [Full Text] [Related]
6. [Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].
Bukhman VM; Lichinitser MR; Svet-Moldavskiĭ GIa; Mkheidze DM
Biull Eksp Biol Med; 1978 Mar; 85(3):340-3. PubMed ID: 276385
[TBL] [Abstract][Full Text] [Related]
7. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
8. Observations on toxicity and clinical trials with daunomycin.
Serpick AA; Henderson ES
Pathol Biol; 1967 Oct; 15(19):909-12. PubMed ID: 4967536
[No Abstract] [Full Text] [Related]
9. Karyotypes of the 5-azacytidine-sensitive and -resistant line of AKR mouse leukemia.
Seifertová M
Neoplasma; 1981; 28(3):317-23. PubMed ID: 6170003
[TBL] [Abstract][Full Text] [Related]
10. [Clinical pharmacology of 5-azacytidine].
Robak T
Pol Tyg Lek; 1984 Feb; 39(7):215-8. PubMed ID: 6205386
[No Abstract] [Full Text] [Related]
11. [Clinical pharmacology of mitoxantrone].
Robak T; Drzewoski J
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1473-5. PubMed ID: 3913945
[No Abstract] [Full Text] [Related]
12. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice.
Neil GL; Moxley TE; Kuentzel SL; Manak RC; Hanka LJ
Cancer Chemother Rep; 1975; 59(3):459-65. PubMed ID: 54211
[TBL] [Abstract][Full Text] [Related]
13. Screening study on Taiwan plants for antitumor activities.
King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
[No Abstract] [Full Text] [Related]
14. [6-Thioguanine in the chemotherapy of leukemias].
Zidermane AA
Vopr Onkol; 1979; 25(1):74-83. PubMed ID: 284664
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.
Kelly CJ; Gaudio L; Yesair DW; Schoenemann PT; Wodinsky I
Cancer Treat Rep; 1978 Jul; 62(7):1025-32. PubMed ID: 80268
[TBL] [Abstract][Full Text] [Related]
16. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
Lu LJ; Randerath K
Mol Pharmacol; 1984 Nov; 26(3):594-603. PubMed ID: 6208475
[TBL] [Abstract][Full Text] [Related]
17. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
[TBL] [Abstract][Full Text] [Related]
18. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
19. Depression of polyamine synthesis in L1210 leukemic mice during treatment with a potent antileukemic agent, 5-azacytidine.
Heby O; Russell DH
Cancer Res; 1973 Jan; 33(1):159-65. PubMed ID: 4118428
[No Abstract] [Full Text] [Related]
20. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
Masi M; Vivarelli F; Paolucci P; Vecchi V
Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
